메뉴 건너뛰기




Volumn 68, Issue 3, 2005, Pages 314-318

The management of patients with mild hepatitis C

Author keywords

Liver biopsy; Mild hepatitis C; Persistently normal ALT

Indexed keywords

AMINOTRANSFERASE; PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

EID: 26944490728     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (7)

References (20)
  • 1
    • 0036829649 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C, 10-12 June 2002
    • National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C, 10-12 June 2002. Hepatology, 2002, 36: S3-20.
    • (2002) Hepatology , vol.36
  • 4
    • 0037126675 scopus 로고    scopus 로고
    • Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection
    • ALBERTI A., NOVENTA E, BENVEGNÙ L., BOCCATO S., GATTA A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann. Intern. Med., 2002, 137: 961-964.
    • (2002) Ann. Intern. Med. , vol.137 , pp. 961-964
    • Alberti, A.1    Noventa, E.2    Benvegnù, L.3    Boccato, S.4    Gatta, A.5
  • 5
    • 1942467895 scopus 로고    scopus 로고
    • Normal serum aminotransferase concentration and risk of mortality from liver diseases: Prospective cohort study
    • KIM H.C., NAM C.M., JEE S.H., HAN K.H., OH D.K., SUH I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. Br. Med. J., 2004, 328: 983.
    • (2004) Br. Med. J. , vol.328 , pp. 983
    • Kim, H.C.1    Nam, C.M.2    Jee, S.H.3    Han, K.H.4    Oh, D.K.5    Suh, I.6
  • 7
    • 12444261843 scopus 로고    scopus 로고
    • Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels
    • ALBERTI A. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. J. Hepatol., 2005, 42: 266-74.
    • (2005) J. Hepatol. , vol.42 , pp. 266-274
    • Alberti, A.1
  • 10
  • 11
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management and treatment of hepatitis C
    • STRADER D.B., WRIGHT T., THOMAS D.L., SEEFF L.B. Diagnosis, management and treatment of hepatitis C. Hepatology, 2004, 39: 1147-1171.
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.B.1    Wright, T.2    Thomas, D.L.3    Seeff, L.B.4
  • 12
    • 0036829652 scopus 로고    scopus 로고
    • Fibrosis and disease progression in hepatitis C
    • MARCELLIN P., ASSELAH T., BOYER N. Fibrosis and disease progression in hepatitis C. Hepatology, 2002, 36: S47-S56.
    • (2002) Hepatology , vol.36
    • Marcellin, P.1    Asselah, T.2    Boyer, N.3
  • 14
    • 0037383495 scopus 로고    scopus 로고
    • A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase
    • HUI C.K., BELAYE T., MONTEGRANDE K., WRIGHT T.L. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J. Hepatol., 2003, 38: 511-517.
    • (2003) J. Hepatol. , vol.38 , pp. 511-517
    • Hui, C.K.1    Belaye, T.2    Montegrande, K.3    Wright, T.L.4
  • 15
    • 0038352047 scopus 로고    scopus 로고
    • Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population
    • SALOMON J.A., WEINSTEIN M.C., HAMMITT J.K., GOLDIE S.J. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. J. Am. Med. Assoc., 2003, 290: 228-237.
    • (2003) J. Am. Med. Assoc. , vol.290 , pp. 228-237
    • Salomon, J.A.1    Weinstein, M.C.2    Hammitt, J.K.3    Goldie, S.J.4
  • 16
  • 18
    • 2142695339 scopus 로고    scopus 로고
    • A health economic model to assess the long term effects and cost-effectiveness of PEG IFN α-2a in hepatitis C virus infected patients
    • ANNEMANS L., WARIE H., NECHELPUT M., PERAUX B. A health economic model to assess the long term effects and cost-effectiveness of PEG IFN α-2a in hepatitis C virus infected patients. Acta Gastroenterol. Belg., 2004, 67: 1-8.
    • (2004) Acta Gastroenterol. Belg. , vol.67 , pp. 1-8
    • Annemans, L.1    Warie, H.2    Nechelput, M.3    Peraux, B.4
  • 20
    • 26944472957 scopus 로고    scopus 로고
    • Cost-effectiveness of interferon α or peginterferon β, with ribavirin for histologically mild chronic hepatitis C
    • Epub June 30, 2005
    • GRIEVE R., ROBERTS J., WRIGHT M., SWEETING M., DEANGELIS D., ROSENBERG W., BASSENDINE M., MAIN J., THOMAS H. Cost-effectiveness of interferon α or peginterferon β, with ribavirin for histologically mild chronic hepatitis C. Gut, 2005 (Epub June 30, 2005).
    • (2005) Gut
    • Grieve, R.1    Roberts, J.2    Wright, M.3    Sweeting, M.4    Deangelis, D.5    Rosenberg, W.6    Bassendine, M.7    Main, J.8    Thomas, H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.